THE APPLICATION OF GENOMICS IN ASBESTOS AND TALC CASES: DR. LEN VAN ZYL WILL BE SPEAKING AT THE PERRIN NATIONAL ASBESTOS LITIGATION CONFERENCE

Posted by on August 14, 2019

On September 9-11, Dr. Len van Zyl of ToxicoGenomica will be speaking at Perrin Conferences’ National Asbestos Litigation Conference at the  Fairmont San Francisco Hotel, San Francisco, CA. This marks the tenth anniversary of the three-day conference which provides attendees with a deeper understanding of the trends currently driving asbestos litigation and the impact these
Read More

E-Cigarette Expert Witness Teams Will be Key as Litigation Increases: Do E-Cigarettes Cause BOOP, Strokes and Seizures?

Posted by on July 31, 2019

E-Cigarette Expert Witness Teams Will be Key as Litigation Increases E-cigarettes and other reduced risk nicotine products (such as smokeless tobacco, heated tobacco, and tobacco-free nicotine products) have generated enormous interest across a spectrum of stakeholders, including smokers who have reportedly quit smoking using one or more of these new (potentially) reduced risk products. Regulators
Read More

Animals Are Not Humans: New Study Identifies Interspecies Differences in PFAS Toxicokinetics

Posted by on July 22, 2019

In a recently published article, Pizzurro and colleagues report several important interspecies differences in perfluoroalkyl substances (PFAS) toxicokinetics. These data represent some of the first evidence for variation in absorption, distribution, metabolism, and excretion (ADME) of PFAS across different species. For PFAS defendants, this paper provides support that pharmacokinetics must be taken into consideration when
Read More

Analytical Challenges in PFAS Detection: The Potential for False Positive Results

Posted by on July 10, 2019

This post was co-authored with Tova Werblowsky, Ph.D., a computational physical chemist and associate professor of chemistry at Touro College What are PFAS? Per- and polyfluoroalkyl substances (PFAS) are a diverse group of chemical compounds that resist degradation in the environment. Because PFAS are impervious to water and heat, these compounds have been used in
Read More

Is Litigation on the Horizon for Sunscreen Manufacturers?

Posted by on June 25, 2019

On May 6, 2019, a study published in the Journal of the American Medical Association reported that several sunscreens used under maximal conditions resulted in plasma concentrations of active ingredients that exceeded the threshold limit established by the U.S. Food and Drug Administration (FDA). The fact that an ingredient is absorbed through the skin and
Read More

E-Cigarette Litigation is Heating Up and The Science is Too

Posted by on June 6, 2019

Manufacturers, retailers, and distributors of e-cigarettes are likely to be defending themselves in against a variety of claims involving these products. The e-cigarette litigation landscape is evolving quickly with several high-profile lawsuits or investigations launched over the past several months by Attorneys General of Massachusetts, Connecticut and North Carolina, a State Prosecutor in an Illinois
Read More

New PFAS Legislation Will Have Big Impact on Litigation

Posted by on June 3, 2019

Recently, both the U.S. House of Representatives and Senate held separate legislative hearings to address potential health and environmental impacts of pre-/polyfluorinated substances (PFAS). On May 15, 2019, the House Subcommittee on Environment and Climate Change held a hearing to consider a series of bills aimed at reducing potential environmental and health risks associated with
Read More

Can Smoking Cause Mesothelioma?

Posted by and on May 16, 2019

The causal relationship between smoking and lung cancer is one of the strongest and most well established in all the health sciences. Asbestos defense attorneys have therefore been eager to determine if there is a causal relationship between smoking and mesothelioma. If such a relationship were identified, in certain cases with the right case-specific facts,
Read More

PFAS Inspired Litigation: An Increasing Number of Entities are at Risk

Posted by on May 8, 2019

Poly- and per-fluorinated alkyl substances (PFAS) are a group of synthesized chemicals that have been used for more than 50 years across many types of industries. For instance, PFAS compounds are widely used in non-stick products (e.g., Teflon), water- and/or stain-proof fabrics (e.g., clothing, furniture), food contact materials (e.g., certain types of cardboard), firefighting foams,
Read More

Signature Mutations Might be the Best Alternative Cause Defense You Never Heard Of

Posted by and on April 29, 2019

Genetic knowledge continues to increase at a rapid pace, transforming not only the practice of medicine but also toxic tort litigation. See our previous posts on this topic (e.g., here and here), our webinar, and our comprehensive white paper titled The Litigator’s Guide to Using Genomics in a Toxic Tort Case for more detailed information
Read More